Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of small molecule compound antibody based on high-throughput sequencing and hybrid hybridoma technology

A technology for cloning antibodies and nucleic acid molecules, which is applied in the fields of immunology and genetic engineering, can solve the problems of difficulty in obtaining rabbit myeloma cells, limited application, and inability to establish and promote the technology, and achieve the problem of limited source of rabbit tumor cells and high sensitivity , high stability effect

Active Publication Date: 2021-05-14
北京明日达科技发展有限责任公司
View PDF15 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, rabbit tumor cells are within the scope of patent protection, which makes it difficult to obtain corresponding rabbit myeloma cell lines, which limits its application in scientific research, making this technology unable to be established and promoted as an experimental platform for scientific research institutions
Therefore, it is challenging to prepare rat and rabbit monoclonal antibodies by conventional methods

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of small molecule compound antibody based on high-throughput sequencing and hybrid hybridoma technology
  • Preparation method of small molecule compound antibody based on high-throughput sequencing and hybrid hybridoma technology
  • Preparation method of small molecule compound antibody based on high-throughput sequencing and hybrid hybridoma technology

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0047]Furthermore, the present invention provides a method for preparing monoclonal antibodies based on high-throughput sequencing technology.

[0048] Furthermore, the present invention provides the application and promotion of a monoclonal antibody expressed based on the variable region sequence of the antibody in the field of small molecule detection.

[0049] Further, the present invention is realized through the following technical solutions:

[0050] The preparation method of ractopamine immunogen (RAC-BSA) and coating former (RAC-OVA) comprises:

[0051] Hapten 1 was covalently linked to BSA / OVA by the glutaraldehyde method to prepare the immunogen and coating agent respectively as follows: 20 mg of Hapten 1 was mixed with 40 mg of BSA or OVA in 5 mL of PBS (pH 7.4). Glutaraldehyde (1 mL, 0.5% solution) was added dropwise to the mixture, stirred at room temperature for 3 h, then dialyzed against PBS for 3 days, and stored at 20° C. until use.

[0052] The immunization...

Embodiment 1

[0062] The immunization of embodiment 1 rat and rabbit

[0063] The concentration of the immunogen (RAC-BSA) was adjusted to 1 mg / mL with PBS buffer, and the concentration of the immunogen was determined by the Bicinchoninic Acid method.

[0064] Take 5 New Zealand white rabbits, numbered RAC-BSA-1, RAC-BSA-2, RAC-BSA-3, RAC-BSA-4 and RAC-BSA-5 respectively. Take 5 Wistar rats, numbered RAC-BSA-6, RAC-BSA-7, RAC-BSA-8, RAC-BSA-9 and RAC-BSA-10. The preparation method of the first immunoemulsified preparation: Take 4.0 mL of immunogen with a concentration of 1 mg / mL, then mix it with an equal volume of Freund's complete adjuvant and emulsify it. The preparation method of boosted immunoemulsification preparation: Take 4.0 mL of immunogen with a concentration of 1 mg / mL, then mix and emulsify with an equal volume of Freund's incomplete adjuvant. The emulsified adjuvant prepared above was injected into the neck and back of rabbits and rats by multi-point dispersed injection (the...

Embodiment 2

[0065] Example 2 Screening of Rat and Rabbit Antisera

[0066] The titer and sensitivity of the antiserum obtained one week after immunization were tested. The method used to measure antiserum titer is indirect ELISA; the method used to measure sensitivity is indirect competition ELISA.

[0067] The steps of indirect ELISA are as follows:

[0068] Dilute the coated RAC-OVA to 0.1 μg / mL with carbonate buffer (pH 9.6), coat the ELISA plate with an amount of 100 μL / well, incubate at 37° C. for 2 h, and then wash the plate 3 times with PBST solution. The ELISA plate was then blocked with 2% skimmed milk powder (150 μL / well), incubated at 37° C. for 1 h, washed three times with PBST solution, and patted dry. The antiserum was serially diluted with PBS, starting from a dilution of 1:4000, with a gradient of 2, a total of 8 dilutions. Add 50 μL of PBS buffer and 50 μL of serially diluted antiserum solution to the coated ELISA plate, incubate at 37°C for 30 min, then wash with PBST...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a method for preparing small molecular compound antibodies based on high-throughput sequencing and hybrid hybridoma technology. Including: 1) According to the structure of the small molecule compound M, design a hapten, synthesize an immunogen, and immunize experimental animals; then collect animal serum to measure the titer, and select immunized animals with high titer to extract B lymphocytes; 2) B lymphocytes Fusion with mouse myeloma cells to obtain heterozygous hybridoma cells; 3) Screen positive hybridoma cells and expand culture in vitro; 4) Perform transcriptome sequencing on positive hybridoma cells to obtain the coding sequences of antibody heavy and light chains , and then use the prokaryotic or eukaryotic expression system to prepare the antibody of the small molecule compound M. The invention effectively solves the problems of difficult preparation of traditional rat monoclonal antibody ascites and limited source of rabbit tumor cells, and finally obtains monoclonal antibody with high specificity, high sensitivity and high stability. The method has great advantages in scientific research and practical application Very broad prospects.

Description

technical field [0001] The invention relates to the technical fields of immunology and genetic engineering, in particular to a method for preparing small molecular compound antibodies based on high-throughput sequencing and hybrid hybridoma technology. Background technique [0002] Since Kohler and Milstein established hybridoma technology in 1975, the development and application of monoclonal antibodies have developed rapidly. However, because the mouse immune system cannot recognize the mouse-derived immunogen, the affinity of mouse monoclonal antibody is lower than that of rats, rabbits and other animals, and the amount of ascites in mice is small, so many rat and rabbit monoclonal antibodies have been produced successively. Research on the preparation of cloned antibodies. After 1979, related studies on the preparation of rat-rat monoclonal antibodies appeared one after another. The relatively mature method of rat-rat hybridoma technology is to fuse LOU / C rat splenocyt...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K16/44C12N15/13G01N33/577G01N33/53
CPCC07K16/44C07K2317/33G01N33/5308G01N33/577
Inventor 王战辉沈建忠温凯江海洋于雪芝余文博李红芳段长飞史为民
Owner 北京明日达科技发展有限责任公司